Project support for a Phase 1 clinical trial of new broadly neutralizing anti-HIV monoclonal antibodies (bnAbs) to assess their safety and potential to prevent vertical HIV transmission in infants
Project support to finalize a four-year collaborative study to understand the effects of HIV on the central nervous system and the development of lymphatic reservoirs in children and adolescents, to enable future HIV cure efforts
Project support to develop manufacturing technology for anti-retroviral active pharmaceutical ingredients to localize the production of key HIV products
Project support for the Beginnings Fund, an initiative that aims to eliminate preventable maternal and newborn deaths and stillbirths by increasing access to evidence-based products, equipment, workforce, and interventions during pregnancy, birth, and the post-natal period
Project support to continue institutionalizing community health workers, by strengthening financing, leadership and governance, policy, and coordination for an integrated community health system
Project support to continue institutionalizing community health workers, by strengthening financing, leadership and governance, policy, and coordination for an integrated community health system
General support to an organization scaling its daily school feeding program to reach one million children in Kenya, and providing support to other African countries in designing and implementing effective school feeding programs
General support for an organization supporting African networks, organizations, and governments to design and roll out best practices, policies, and tools for ECD
Project support to provide an emergency supply of essential newborn equipment to stabilize a heightened number of low birth weight newborns presenting at Rahima Moosa Mother and Child Hospital in Johannesburg
General support for a social enterprise providing quality improvement services to a network of self-sustaining, low-cost ECD centers in urban Kenya and Addis Ababa
Project support to the management of WHO's Global Accelerator for Pediatric Formulations (GAP-f) network, which is focused on accelerating access to safe, effective, quality, affordable pediatric medicines